Literature DB >> 24748401

Anesthesia for aortic reconstruction in a child with PHACE syndrome.

Tatsuyuki Imada1, Ryu Okutani, Yutaka Oda.   

Abstract

PHACE syndrome is a neurocutaneous syndrome characterized by the association of large cutaneous hemangiomas and the cardiac and cerebral vascular anomalies. We report a 6-year-old female with PHACE syndrome presented with left facial hemangiomas, cystic lesion in the cerebral posterior fossa, coarctation of the aorta, aplasia of the left vertebral artery and stenosis of the left internal carotid artery. Surgical repair of the aorta with left heart bypass under beating heart was scheduled. We monitored regional cerebral oxygen saturation (rSO2) with infrared spectroscopy in order to detect cerebral hypoperfusion. A decrease of rSO2 ipsilateral to the cerebrovascular anomalies occurred during anastomosis of the aorta, which was treated by reducing the flow rate of left heart bypass and by increasing the inhalational oxygen concentration. As children with PHACE syndrome are frequently accompanied with cerebrovascular anomalies and at a risk of cerebral hypoperfusion, prevention of cerebral hypoperfusion is crucially important during general anesthesia.

Entities:  

Mesh:

Year:  2014        PMID: 24748401     DOI: 10.1007/s00540-014-1828-4

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  12 in total

1.  Monitoring cerebral oxygenation in a pediatric patient undergoing surgery for vascular ring.

Authors:  Reena K Joshi; Pablo Motta; Mayumi Horibe; Emad Mossad
Journal:  Paediatr Anaesth       Date:  2006-02       Impact factor: 2.556

Review 2.  Review article: cerebral near-infrared spectroscopy in adults: a work in progress.

Authors:  Arnab Ghosh; Clare Elwell; Martin Smith
Journal:  Anesth Analg       Date:  2012-11-09       Impact factor: 5.108

3.  Selective use of left heart bypass for aortic coarctation.

Authors:  Andrew C Fiore; Mark Ruzmetov; Robert G Johnson; Mark D Rodefeld; Karen Rieger; Mark W Turrentine; John W Brown
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

4.  Anesthesia management in a child with PHACE syndrome and agenesis of bilateral internal carotid arteries.

Authors:  Aurélia Javault; Olivier Metton; Olivier Raisky; Dominique Bompard; Mohamed Hachemi; Delphine Gamondes; Jean Ninet; Jean Neidecker; Jean-Jacques Lehot; Maxime Cannesson
Journal:  Paediatr Anaesth       Date:  2007-10       Impact factor: 2.556

5.  PHACES association: a vasculocutaneous syndrome.

Authors:  Rohit P Rao; Beth A Drolet; Kristen E Holland; Peter C Frommelt
Journal:  Pediatr Cardiol       Date:  2008-04-22       Impact factor: 1.655

6.  Cerebral regional oxygenation during aortic coarctation repair in pediatric population.

Authors:  Ahmed Farouk; Mohsen Karimi; Mark Henderson; Jacob Ostrowsky; Ernest Siwik; Hani Hennein
Journal:  Eur J Cardiothorac Surg       Date:  2008-05-16       Impact factor: 4.191

7.  Consensus Statement on Diagnostic Criteria for PHACE Syndrome.

Authors:  Denise Metry; Geoffrey Heyer; Christopher Hess; Maria Garzon; Anita Haggstrom; Peter Frommelt; Denise Adams; Dawn Siegel; Karla Hall; Julie Powell; Ilona Frieden; Beth Drolet
Journal:  Pediatrics       Date:  2009-10-26       Impact factor: 7.124

8.  Cerebral monitoring by means of oximetry and somatosensory evoked potentials during carotid endarterectomy.

Authors:  H Cho; E M Nemoto; H Yonas; J Balzer; R J Sclabassi
Journal:  J Neurosurg       Date:  1998-10       Impact factor: 5.115

9.  PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities.

Authors:  I J Frieden; V Reese; D Cohen
Journal:  Arch Dermatol       Date:  1996-03

10.  Cerebral ischaemia during cardiac surgery in children detected by combined monitoring of BIS and near-infrared spectroscopy.

Authors:  M Hayashida; N Kin; T Tomioka; R Orii; H Sekiyama; H Usui; M Chinzei; K Hanaoka
Journal:  Br J Anaesth       Date:  2004-03-19       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.